Liposuction is a common cosmetic procedure with a low incidence of bacterial infection. Even more rare is the postoperative complication of infection with atypical mycobacteria. Months after the associated procedure is performed, atypical mycobacterial infection often presents with a variable clinical presentation. These characteristics often lead to misdiagnosis and delay in diagnosis. Presented here is a case of Mycobacteria chelonae infection following abdominal liposuction, along with information on diagnosis and management. To avoid a delay in diagnosis, it is essential to include atypical mycobacteria in the differential diagnosis when evaluating a patient with a rash with a history of an invasive cosmetic procedure.
Get full access to this article
View all access options for this article.
References
1.
American Society for Aesthetic Plastic Surgery. Cosmetic Surgery National Data Bank Statistics, 2008.
2.
SafranekTJJarvisWRCarsonLA, Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987;317:197–201.
3.
DessyLMazzocchiMFioramontiP, Conservative management of local Mycobacterium chelonae infection after combined liposuction and lipofilling. Aesthetic Plast Surg. 2006;30:717–722.
4.
FrankNCabieAVilletteB, Treatment of Mycobacterium chelonae-induced skin infections with clarithromycin. J Am Acad Dermatol. 1993;28:1019–1021.
5.
LevineNRothschildJ. Treatment of Mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol. 1991;24:867–870.
6.
WoodsGWashingtonJII. Mycobacteria other than Mycobacterium tuberculosis: Review of microbiologic and clinical aspects. Rev Infect Dis. 1987;9:275–294.
7.
HoMHoCChongL. Atypical mycobacterial cutaneous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J. 2006;12:21–26.
8.
WallaceRBrownBOnyiG. Skin, soft tissue and bone infections due to Mycobacteria chelonae: Importance of prior corticosteroid therapy, frequency of disseminated infections and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166:405–412.
9.
ShaferRSierraM. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. Clin Infect Dis. 1992;15:161–162.
10.
WallaceRSwensonJSilcoxV, Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonae on the basis of in vitro susceptibilities. J Infect Dis. 1985;152:500–514.
MurilloJTorresJBofillL, Skin and wound infection by rapidly growing mycobacteria: An unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol. 2000;136:1347–1352.
13.
McFarlandEKuritzkesD. Clinical features and treatment of infection due to Mycobacterium fortuitum-chelonae complex. Curr Clin Top Infect Dis. 1993;13:188–202.
14.
TsukamuraMNakamuraEKuritaI, Isolation of Mycobacterium chelonae subspecies chelonae (Mycobacterium borstelense) from pulmonary lesions of nine patients. Am Rev Respir Dis. 1973;108:683–685.
15.
MeyersHBrown-ElliottBMooreD, An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis. 2002;34:1500–1507.
16.
GarmanMOrengoI. Unusual infectious complications of dermatologic procedures. Dermatol Clin. 2003;21:321–335.
17.
UslanDKowalskiTWengenackN, Skin and soft tissue infections due to rapidly growing mycobacteria. Arch Dermatol. 2006;142:1287–1292.
18.
TerrySTimothyNZurloJ, Mycobacterium chelonae: Nonhealing leg ulcers treated successfully with an oral antibiotic. J Am Board Fam Pract. 2001;14:457–461.
19.
VemulapalliRCanteyJSteedL, Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: Case report and literature review. J Infect. 2001;43:163–168.
20.
WallaceRMeierABrownB, Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996;40:1676–1681.
